RxDoctor Payments DataLook up a doctor →

Melisa Wilson, APRN

Acute Care · Orlando, FLNPI 1780618355

Payments from drug & device makers

$3,618,643in general payments, 2019–2025

Across 467 payments — averaging $7748.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$3.4M
  • United Therapeutics Corporation$121K
  • Actelion Pharmaceuticals US, Inc.$79K
  • Actelion Pharmaceuticals, Ltd$13K
  • Bayer$10K
  • Johnson & Johnson$3K
  • plus $653 from 7 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,618,643 in reported general payments places this provider in the 95th percentile of 1,150 acute care providers in Florida.

See all acute care providers in Florida

Medicare billing

Part B allowed, 2024
$4,844
Medicare patients
60
Services billed
86

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →